Study may offer doctors a more effective way to treat neuroblastoma

by Bob Yirka , Medical XpressShown is a microscopic view of a typical neuroblastoma with rosette formation. Magnified x40. Credit: Dr. Maria Tsokos, National Cancer InstituteA very large team of resea

Updated on: April 18,2024

Study may offer doctors a more effective way to treat neuroblastoma

by Bob Yirka , Medical XpressShown is a microscopic view of a typical neuroblastoma with rosette formation. Magnified x40. Credit: Dr. Maria Tsokos, National Cancer InstituteA very large team of resea

Updated on:April 18,2024

The ways astronauts prep for spaceflight could benefit cancer patients, say researchers

by Cell PressNASA astronaut Reid Wiseman, Expedition 40 flight engineer, equipped with a bungee harness, exercises on the Combined Operational Load Bearing External Resistance Treadmill (COLBERT)

Updated on: June 06,2024

The ways astronauts prep for spaceflight could benefit cancer patients, say researchers

by Cell PressNASA astronaut Reid Wiseman, Expedition 40 flight engineer, equipped with a bungee harness, exercises on the Combined Operational Load Bearing External Resistance Treadmill (COLBERT)

Updated on:June 06,2024

New approach to screening has potential to extend survival in glioblastoma brain cancer

byInstitute of Cancer ResearchCredit:Cancers(2023). DOI: 10.3390/cancers15123131A new form of screening may improve survival rates among people with a fast-growing type of brain tumo

Updated on: January 12,2024

New approach to screening has potential to extend survival in glioblastoma brain cancer

byInstitute of Cancer ResearchCredit:Cancers(2023). DOI: 10.3390/cancers15123131A new form of screening may improve survival rates among people with a fast-growing type of brain tumo

Updated on:January 12,2024

Investigational drug may combat brain tumors by targeting cancer cells' fat production

by Katie Marquedant,Massachusetts General HospitalCorrelation analysis between SCD expression and sensitivity to YTX-7739. (A) Immunoblot analysis (left) of SCD expression in YTX-7739-sensitive

Updated on: February 01,2024

Investigational drug may combat brain tumors by targeting cancer cells' fat production

by Katie Marquedant,Massachusetts General HospitalCorrelation analysis between SCD expression and sensitivity to YTX-7739. (A) Immunoblot analysis (left) of SCD expression in YTX-7739-sensitive

Updated on:February 01,2024

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on: January 13,2024

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on:January 13,2024

Discovery of new mechanism explains how ovarian cancer disables immune cells

byWeill Cornell Medical CollegeThis confocal micrograph shows two proteins,TAGLN2 (green) and FABP5 (red), are found together (yellow) on the surfaces of T cells, enabling the cells to pick up l

Updated on: November 11,2024

Discovery of new mechanism explains how ovarian cancer disables immune cells

byWeill Cornell Medical CollegeThis confocal micrograph shows two proteins,TAGLN2 (green) and FABP5 (red), are found together (yellow) on the surfaces of T cells, enabling the cells to pick up l

Updated on:November 11,2024

Inflammatory-nutritional score helps predict survival in new multiple myeloma

by Elana GotkineFor patients with newly diagnosed multiple myeloma (NDMM), a nomogram based on the inflammatory-nutritional score (INS) may help to predict survival, according to a study published onl

Updated on: January 16,2024

Inflammatory-nutritional score helps predict survival in new multiple myeloma

by Elana GotkineFor patients with newly diagnosed multiple myeloma (NDMM), a nomogram based on the inflammatory-nutritional score (INS) may help to predict survival, according to a study published onl

Updated on:January 16,2024

New PET tracer shows promise for uPAR-targeted therapy of neuroendocrine neoplasms

by Society of Nuclear Medicine and Molecular ImagingGraphical abstract. Credit:Journal of Nuclear Medicine(2022). DOI: 10.2967/jnumed.121.263177A novel PET radiotracer can accurately asses

Updated on: January 11,2024

New PET tracer shows promise for uPAR-targeted therapy of neuroendocrine neoplasms

by Society of Nuclear Medicine and Molecular ImagingGraphical abstract. Credit:Journal of Nuclear Medicine(2022). DOI: 10.2967/jnumed.121.263177A novel PET radiotracer can accurately asses

Updated on:January 11,2024

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on: March 05,2024

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on:March 05,2024

DDX41 and its unique contribution to myeloid leukemogenesis

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainIn an editorial paper published inOncotargettitled, "DDX41 and its unique contribution to myeloid leukemogenesis," researc

Updated on: August 03,2024

DDX41 and its unique contribution to myeloid leukemogenesis

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainIn an editorial paper published inOncotargettitled, "DDX41 and its unique contribution to myeloid leukemogenesis," researc

Updated on:August 03,2024

Scientists discover how satellite RNA leads to cancer

by Salk InstituteCell with injected hSATa RNA (left) shows a high level of a marker for DNA damage, γH2AX (middle). Merge image (right) shows satellite RNA and γH2AX in cells; DNA is blue. Credit

Updated on: March 12,2024

Scientists discover how satellite RNA leads to cancer

by Salk InstituteCell with injected hSATa RNA (left) shows a high level of a marker for DNA damage, γH2AX (middle). Merge image (right) shows satellite RNA and γH2AX in cells; DNA is blue. Credit

Updated on:March 12,2024

Invention makes biopsies less invasive and more informative

by National University of SingaporeThe new STAMP technology developed by Assistant Professor Shao Huilin (left), doctoral student Mr Noah Sundah (right) and their team from NUS Institute for Heal

Updated on: April 18,2024

Invention makes biopsies less invasive and more informative

by National University of SingaporeThe new STAMP technology developed by Assistant Professor Shao Huilin (left), doctoral student Mr Noah Sundah (right) and their team from NUS Institute for Heal

Updated on:April 18,2024